2012 Midyear Clinical Meeting
Click here to go to the previous page
Bet on Red: New Challenges and Therapies for Bleeding
Track:
Education Sessions (CE)
Program Code: 251-L01
Date: Tuesday, December 4, 2012
Time: 9:30 AM to 11:00 AM EST
Location:
Mandalay Bay H, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
William Dager,
PharmD, BCPS, Pharmacist Specialist,
University of California Davis Medical Center
|
William E. Dager, Pharm.D, BCPS (AQ Cardiology)
FCSHP, FCCP, FCCM, FASHP
Pharmacist Specialist, UC Davis Medical Center (UCDMC)
Clinical Professor of Pharmacy
University of California, San Francisco
Clinical Professor of Medicine
School of University of California, Davis
Clinical Professor of Pharmacy, Touro School of Pharmacy
William E. Dager, received his Pharm.D. from the University of California, San Francisco (UCSF) and completed a residency at UCDMC. He also completed a Nephrology Pharmaceutical Care Preceptorship at the University of Pittsburgh, School of Pharmacy. He is a board certified pharmacotherapy specialist with added qualifications in cardiology, who is a clinical specialist at UCDMC where he manages difficult cases in anticoagulation, pharmacokinetics or other critical care related situations. He is the director of the PGY-2 residency in cardiology. He currently holds four academic positions primarily as volunteer faculty.
Dr Dager is a recipient of multiple teaching and mentoring awards including the ACCP Best Practice award. He is a reviewer and/or editorial board member for multiple medical journals including chair of the Editorial Advisory Board panel on anticoagulation for the Annals of Pharmacotherapy. He is also a site coordinator for the ASHP foundation anticoagulation preceptorship.
Dr Dager has authored numerous articles, reviews book chapters in including the ASHP Anticoagulation Therapy POC guide. He is an active lecturer and has research interests involving anticoagulation, critical care, cardiovascular disease and pharmacokinetics/pharmacodynamics.
|
Robert MacLaren,
PharmD, FCCM, Associate Professor,
University of Colorado School of Pharmacy
|
Robert MacLaren, Pharm.D., FCCM, FCCP, is Associate Professor in the Department of Clinical Pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Aurora, Colorado. He is a clinical pharmacist in the medical intensive care unit at the University of Colorado Hospital. Dr. MacLaren serves as co-director of the critical care residency and fellowship programs at the University of Colorado.
After completing his undergraduate degree in pharmacy at the University of British Columbia, Dr. MacLaren earned his Doctor of Pharmacy degree at the University of Utah and completed a critical care specialty residency in Memphis at the University of Tennessee. He worked for two years as a critical care specialist at the Queen Elizabeth II Health Sciences Centre in Halifax, Canada, before joining the faculty at the University of Colorado.
Dr. MacLaren is a fellow of the Society of Critical Care Medicine and the American College of Clinical Pharmacy. His clinical research interests include gastrointestinal motility dysfunction associated with critical illness and modes of providing patient comfort. He also conducts animal studies of drug-induced liver toxicity and has been involved with outcomes research of pharmacologic therapies and the impact of pharmacists in the intensive care unit. He has authored over 75 articles and has been an invited speaker at national and international meetings.
|
Asad Patanwala,
PharmD, BCPS, Assistant Professor,
University of Arizona
|
Dr. Asad (Sid) Patanwala is an assistant professor at the University of Arizona, College of Pharmacy in Tucson, Arizona. He practices as a clinical pharmacy specialist in emergency medicine at University of Arizona Medical Center and precepts students and residents on the trauma team and in the emergency department. Dr. Patanwala has published several articles in high-impact peer-reviewed emergency medicine journals, such as the Annals of Emergency Medicine, Academic Emergency Medicine, The Journal of Emergency Medicine and many others. He currently serves on the editorial advisory board for the American Journal of Health-System Pharmacy. In 2008, he was awarded the Junior Investigator grant from the American Society of Health-System Pharmacy Foundation to study medication errors in the emergency department. In 2009, he completed the American College of Clinical Pharmacy Focused Investigator Training Program. Dr. Patanwala has given several presentations at national and international meetings, such as the American College of Emergency Physicians, Society of Critical Care Medicine, American College of Clinical Pharmacy and American Society of Health-System Pharmacists.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Asad Patanwala,
PharmD, BCPS, Assistant Professor,
University of Arizona
|
Dr. Asad (Sid) Patanwala is an assistant professor at the University of Arizona, College of Pharmacy in Tucson, Arizona. He practices as a clinical pharmacy specialist in emergency medicine at University of Arizona Medical Center and precepts students and residents on the trauma team and in the emergency department. Dr. Patanwala has published several articles in high-impact peer-reviewed emergency medicine journals, such as the Annals of Emergency Medicine, Academic Emergency Medicine, The Journal of Emergency Medicine and many others. He currently serves on the editorial advisory board for the American Journal of Health-System Pharmacy. In 2008, he was awarded the Junior Investigator grant from the American Society of Health-System Pharmacy Foundation to study medication errors in the emergency department. In 2009, he completed the American College of Clinical Pharmacy Focused Investigator Training Program. Dr. Patanwala has given several presentations at national and international meetings, such as the American College of Emergency Physicians, Society of Critical Care Medicine, American College of Clinical Pharmacy and American Society of Health-System Pharmacists.
|
Description
Reversal of New Oral Anticoagulants, William E. Dager, PharmD, BCPS, FASHP
New Therapies for Traumatic and Surgical Bleeding, Robert MacLaren, PharmD, FCCM
Optimizing the Use of Factor Products, Asad E. Patanwala, PharmD, BCPS
- Develop a plan for bleeding cessation due to traumatic hemorrhage and in the perioperative setting.
- Evaluate dosing considerations for factor products such as prothrombin complex concentrate and factor VIIa.
- Recommend strategies for the reversal of oral anticoagulants such as direct thrombin inhibitors and factor Xa inhibitors.
